Table 3.
Lists of patents on phage-based cancer treatments (source: USPTO and WIPO/PCT databases).
| Patent Number | Inventors | Title | Published Year |
|---|---|---|---|
| WO2006008312A1 | Udo Blasi, Christine Hohenadl | Bacteriophage and prophage proteins in cancer gene therapy | 2006 |
| US20060058228A1 | Kimberly Kelly, David Jones | Colon tumor specific binding peptides | 2006 |
| US8137693B2 | Valery A. Petrenko | Drug delivery nanocarriers targeted by landscape phage | 2012 |
| US8088887B2 | Han-Chung, WuChin-Tarng Lin, Tong-Young Lee, Szu-Yao Kuo | Peptide-conjugates that bind to VEGF-stimulated or tumor vasculature and methods of treatment | 2012 |
| US8415131B2 | Qian Wang, Kai Li, Charlene Mello | M13 bacteriophage as a chemo-addressable nanoparticle for biological and medical applications | 2013 |
| US9387257B2 | Han-Chung Wu, Yi-Hsuan CHI | Lung cancer specific peptides for targeted drug delivery and molecular imaging | 2016 |
| CN105267973A | Wu Hanzhong, Wu Jianxun | Cancer targeting peptides for enhancing anti-cancer drug delivery and therapeutic efficiencies | 2016 |
| US9226972B2 | Valery A. Petrenko, Deepa Bedi, Olusegun A. Fagbohun, James W. Gillespie | Targeted particles comprising landscape phage fusion proteins and heterologous nucleic acid | 2016 |
| US9744223B2 | Biswajit Biswas, Carl R. Merril, Hossein A. Ghanbari | Therapeutic cancer vaccine targeted to aspartyl-(asparaginyl)-beta-hydroxylase (HAAH) | 2017 |